ArticleGastroenterology research2023

Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn's Disease and Ulcerative Colitis.

Nooraldin Merza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.